LENZ Ebit vs Selling General Administrative Analysis

LENZ Stock

27.99 1.67 6.34%

LENZ Therapeutics financial indicator trend analysis is infinitely more than just investigating LENZ Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LENZ Therapeutics is a good investment. Please check the relationship between LENZ Therapeutics Ebit and its Selling General Administrative accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LENZ Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.

Ebit vs Selling General Administrative

Ebit vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LENZ Therapeutics Ebit account and Selling General Administrative. At this time, the significance of the direction appears to have pay attention.

The correlation between LENZ Therapeutics' Ebit and Selling General Administrative is -0.84. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of LENZ Therapeutics, assuming nothing else is changed. The correlation between historical values of LENZ Therapeutics' Ebit and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of LENZ Therapeutics are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Ebit i.e., LENZ Therapeutics' Ebit and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.84

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Ebit

Selling General Administrative

Most indicators from LENZ Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LENZ Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LENZ Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.At this time, LENZ Therapeutics' Tax Provision is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 1.25 in 2024, whereas Selling General Administrative is likely to drop slightly above 3.8 M in 2024.

	2023	2024 (projected)
Interest Expense	36K	48K
Depreciation And Amortization	2.4M	2.6M

Interest Expense Depreciation And Amortization

LENZ Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Total Liab	Total Current Assets	Short Term Debt	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Net Invested Capital	Property Plant And Equipment Gross	Capital Stock	Net Working Capital	Common Stock
Total Assets		0.43	0.29	0.32	1.0	-0.85	-0.74	0.85	1.0	0.93	0.44	1.0	0.23	0.78	0.74	0.72	0.97	-0.35	0.84	0.91	0.94	-0.64	0.6	0.35	0.59	-0.35
Short Long Term Debt Total	0.43		0.59	0.75	0.4	-0.18	0.08	0.24	0.4	0.58	0.81	0.41	0.97	0.73	0.8	0.68	0.25	0.51	0.69	0.47	0.18	0.09	-0.09	-0.53	-0.13	0.51
Other Current Liab	0.29	0.59		0.97	0.24	-0.29	-0.31	0.28	0.29	0.24	0.86	0.29	0.44	0.17	0.16	0.15	0.25	-0.13	0.21	0.22	0.23	-0.15	0.11	0.09	0.11	-0.13
Total Current Liabilities	0.32	0.75	0.97		0.26	-0.22	-0.23	0.23	0.31	0.31	0.94	0.31	0.61	0.33	0.33	0.32	0.23	0.06	0.31	0.29	0.22	-0.12	0.11	-0.06	0.1	0.06
Total Stockholder Equity	1.0	0.4	0.24	0.26		-0.86	-0.73	0.86	1.0	0.92	0.39	1.0	0.2	0.77	0.74	0.71	0.97	-0.35	0.84	0.89	0.94	-0.62	0.6	0.36	0.59	-0.35
Net Debt	-0.85	-0.18	-0.29	-0.22	-0.86		0.66	-0.99	-0.88	-0.7	-0.18	-0.88	0.01	-0.38	-0.42	-0.27	-0.92	0.47	-0.72	-0.57	-0.81	0.38	-0.36	-0.48	-0.38	0.47
Retained Earnings	-0.74	0.08	-0.31	-0.23	-0.73	0.66		-0.62	-0.75	-0.52	-0.32	-0.75	0.33	-0.32	-0.17	-0.35	-0.81	0.8	-0.26	-0.67	-0.91	0.92	-0.89	-0.84	-0.9	0.8
Cash	0.85	0.24	0.28	0.23	0.86	-0.99	-0.62		0.88	0.7	0.2	0.88	0.06	0.43	0.48	0.31	0.92	-0.37	0.77	0.56	0.8	-0.33	0.34	0.43	0.36	-0.37
Cash And Short Term Investments	1.0	0.4	0.29	0.31	1.0	-0.88	-0.75	0.88		0.91	0.42	1.0	0.2	0.74	0.71	0.68	0.98	-0.36	0.84	0.88	0.95	-0.62	0.59	0.38	0.58	-0.36
Common Stock Shares Outstanding	0.93	0.58	0.24	0.31	0.92	-0.7	-0.52	0.7	0.91		0.47	0.91	0.44	0.89	0.87	0.83	0.82	-0.17	0.89	0.94	0.78	-0.49	0.39	0.03	0.36	-0.17
Total Liab	0.44	0.81	0.86	0.94	0.39	-0.18	-0.32	0.2	0.42	0.47		0.42	0.67	0.57	0.52	0.58	0.31	0.08	0.39	0.51	0.35	-0.31	0.3	-0.08	0.27	0.08
Total Current Assets	1.0	0.41	0.29	0.31	1.0	-0.88	-0.75	0.88	1.0	0.91	0.42		0.21	0.75	0.72	0.69	0.98	-0.36	0.84	0.88	0.95	-0.62	0.59	0.38	0.59	-0.36
Short Term Debt	0.23	0.97	0.44	0.61	0.2	0.01	0.33	0.06	0.2	0.44	0.67	0.21		0.64	0.74	0.6	0.03	0.7	0.6	0.3	-0.05	0.3	-0.29	-0.72	-0.33	0.7
Property Plant And Equipment Net	0.78	0.73	0.17	0.33	0.77	-0.38	-0.32	0.43	0.74	0.89	0.57	0.75	0.64		0.97	0.99	0.62	0.19	0.83	0.88	0.62	-0.41	0.4	-0.19	0.36	0.19
Accounts Payable	0.74	0.8	0.16	0.33	0.74	-0.42	-0.17	0.48	0.71	0.87	0.52	0.72	0.74	0.97		0.92	0.58	0.32	0.91	0.79	0.53	-0.21	0.2	-0.33	0.16	0.32
Non Current Assets Total	0.72	0.68	0.15	0.32	0.71	-0.27	-0.35	0.31	0.68	0.83	0.58	0.69	0.6	0.99	0.92		0.55	0.16	0.72	0.88	0.6	-0.49	0.47	-0.16	0.43	0.16
Non Currrent Assets Other	0.97	0.25	0.25	0.23	0.97	-0.92	-0.81	0.92	0.98	0.82	0.31	0.98	0.03	0.62	0.58	0.55		-0.48	0.75	0.8	0.97	-0.65	0.64	0.53	0.64	-0.48
Other Assets	-0.35	0.51	-0.13	0.06	-0.35	0.47	0.8	-0.37	-0.36	-0.17	0.08	-0.36	0.7	0.19	0.32	0.16	-0.48		0.15	-0.3	-0.55	0.7	-0.56	-0.85	-0.6	1.0
Non Current Liabilities Total	0.84	0.69	0.21	0.31	0.84	-0.72	-0.26	0.77	0.84	0.89	0.39	0.84	0.6	0.83	0.91	0.72	0.75	0.15		0.72	0.62	-0.14	0.13	-0.15	0.11	0.15
Other Current Assets	0.91	0.47	0.22	0.29	0.89	-0.57	-0.67	0.56	0.88	0.94	0.51	0.88	0.3	0.88	0.79	0.88	0.8	-0.3	0.72		0.84	-0.73	0.63	0.19	0.6	-0.3
Other Stockholder Equity	0.94	0.18	0.23	0.22	0.94	-0.81	-0.91	0.8	0.95	0.78	0.35	0.95	-0.05	0.62	0.53	0.6	0.97	-0.55	0.62	0.84		-0.81	0.81	0.63	0.81	-0.55
Net Invested Capital	-0.64	0.09	-0.15	-0.12	-0.62	0.38	0.92	-0.33	-0.62	-0.49	-0.31	-0.62	0.3	-0.41	-0.21	-0.49	-0.65	0.7	-0.14	-0.73	-0.81		-0.94	-0.71	-0.94	0.7
Property Plant And Equipment Gross	0.6	-0.09	0.11	0.11	0.6	-0.36	-0.89	0.34	0.59	0.39	0.3	0.59	-0.29	0.4	0.2	0.47	0.64	-0.56	0.13	0.63	0.81	-0.94		0.75	1.0	-0.56
Capital Stock	0.35	-0.53	0.09	-0.06	0.36	-0.48	-0.84	0.43	0.38	0.03	-0.08	0.38	-0.72	-0.19	-0.33	-0.16	0.53	-0.85	-0.15	0.19	0.63	-0.71	0.75		0.79	-0.85
Net Working Capital	0.59	-0.13	0.11	0.1	0.59	-0.38	-0.9	0.36	0.58	0.36	0.27	0.59	-0.33	0.36	0.16	0.43	0.64	-0.6	0.11	0.6	0.81	-0.94	1.0	0.79		-0.6
Common Stock	-0.35	0.51	-0.13	0.06	-0.35	0.47	0.8	-0.37	-0.36	-0.17	0.08	-0.36	0.7	0.19	0.32	0.16	-0.48	1.0	0.15	-0.3	-0.55	0.7	-0.56	-0.85	-0.6

Click cells to compare fundamentals

LENZ Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
F	Ford Motor
CRM	Salesforce

Additional Tools for LENZ Stock Analysis

When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LENZ Ebit vs Selling General Administrative Analysis

Ebit vs Selling General Administrative

Ebit vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Ebit

Selling General Administrative

LENZ Therapeutics fundamental ratios Correlations

LENZ Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for LENZ Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments

Cash	- 0.99	Net Debt
Net Working Capital	- 0.94	Net Invested Capital
Property Plant And Equipment Gross	- 0.94	Net Invested Capital
Non Currrent Assets Other	- 0.92	Net Debt
Other Stockholder Equity	- 0.91	Retained Earnings
Net Working Capital	- 0.9	Retained Earnings